anisodamine has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YX | 1 |
| Gondaira, F; Kojio, S; Ohmura, M; Ou, ZL; Yamamoto, T; Zhang, HM | 1 |
2 other study(ies) available for anisodamine and Escherichia coli Infections
| Article | Year |
|---|---|
[Effects of anisodamine and ampicillin on cerebrospinal fluid in experimental E coli meningitis].
Topics: Ampicillin; Animals; Drug Therapy, Combination; Endotoxins; Escherichia coli Infections; Female; L-Lactate Dehydrogenase; Male; Malondialdehyde; Meningitis, Bacterial; Rabbits; Solanaceous Alkaloids; Vasodilator Agents | 1993 |
Protective effect of anisodamine against Shiga toxin-1: inhibition of cytokine production and increase in the survival of mice.
Topics: Animals; Cell Line; Cell Survival; Cytokines; Dinoprostone; Escherichia coli Infections; Gene Expression; Humans; Injections, Intraperitoneal; Interleukin-1; Interleukin-8; Male; Mice; Mice, Inbred C57BL; Monocytes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shiga Toxin 1; Solanaceous Alkaloids; Survival Rate; Tumor Necrosis Factor-alpha | 2001 |